{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:52:52Z","timestamp":1791665572365,"version":"4.3.4"},"reference-count":196,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:00:00Z","timestamp":1520467200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2018.00073","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T04:12:55Z","timestamp":1520482375000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications"],"prefix":"10.3389","volume":"9","author":[{"given":"HuaLin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey K.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0960-0760(90)90490-C","article-title":"Neurosteroids: a new brain function?","volume":"37","author":"Baulieu","year":"1990","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1096\/fasebj.6.6.1347506","article-title":"Neuroactive steroids","volume":"6","author":"Paul","year":"1992","journal-title":"FASEB J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pnpbp.2004.11.001","article-title":"Steroids, neuroactive steroids and neurosteroids in psychopathology","volume":"29","author":"Dubrovsky","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","article-title":"Neurosteroids: endogenous role in the human brain and therapeutic potentials","volume":"186","author":"Reddy","year":"2010","journal-title":"Prog Brain Res"},{"key":"B5","first-page":"161","article-title":"Neuroactive steroids and anxiety disorders","volume":"27","author":"Le Mell\u00e9do","year":"2002","journal-title":"J Psychiatry Neurosci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.pbb.2006.07.026","article-title":"Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy?","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"B7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.pbb.2006.07.032","article-title":"Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","article-title":"Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics","volume":"31","author":"Marx","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s002130050916","article-title":"Assessment of neuroleptic-like properties of progesterone","volume":"143","author":"Rupprecht","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"B10","first-page":"RA270","article-title":"The role of neurosteroids in the anxiolytic, antidepressive-and anticonvulsive effects of selective serotonin reuptake inhibitors","volume":"9","author":"Cz\u0142onkowska","year":"2003","journal-title":"Med Sci Monit"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/sj.npp.1300460","article-title":"Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents","volume":"29","author":"Ugale","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jsbmb.2014.09.001","article-title":"Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection","volume":"146","author":"Guennoun","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuroscience.2015.01.019","article-title":"Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe\/PSEN1 mice","volume":"290","author":"Zhang","year":"2015","journal-title":"Neuroscience"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5985021","DOI":"10.1155\/2016\/5985021","article-title":"Neurosteroids involvement in the epigenetic control of memory formation and storage","volume":"2016","author":"Colciago","year":"2016","journal-title":"Neural Plast"},{"key":"B15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0006-8993(93)91524-V","article-title":"Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat","volume":"607","author":"Mayo","year":"1993","journal-title":"Brain Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"14865","DOI":"10.1073\/pnas.94.26.14865","article-title":"Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus","volume":"94","author":"Vall\u00e9e","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0074-7742(01)46066-1","article-title":"Neurosteroids in learning and memory processes","volume":"46","author":"Vall\u00e9e","year":"2001","journal-title":"Int Rev Neurobiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0165-0173(01)00135-7","article-title":"Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging","volume":"37","author":"Vall\u00e9e","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0006-8993(00)01953-3","article-title":"Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse","volume":"858","author":"Ladurelle","year":"2000","journal-title":"Brain Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1017\/S1461145701002462","article-title":"Analysis of neurosteroid levels in attention deficit hyperactivity disorder","volume":"4","author":"Strous","year":"2001","journal-title":"Int J Neuropsychopharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10571-006-9086-0","article-title":"The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders","volume":"27","author":"MacKenzie","year":"2007","journal-title":"Cell Mol Neurobiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.neuint.2007.10.001","article-title":"The complex roles of neurosteroids in depression and anxiety disorders","volume":"52","author":"Longone","year":"2008","journal-title":"Neurochem Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neuroscience.2011.04.010","article-title":"Neurosteroid and GABA-A receptor alterations in Alzheimer\u2019s disease, Parkinson\u2019s disease and multiple sclerosis","volume":"191","author":"Luchetti","year":"2011","journal-title":"Neuroscience"},{"key":"B24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III \u2013 the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr Bull"},{"key":"B25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev.pharmtox.41.1.237","article-title":"Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence","volume":"41","author":"Carlsson","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10571-006-9062-8","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.plefa.2003.08.008","article-title":"From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?","volume":"69","author":"Skosnik","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0074-7742(04)59012-8","article-title":"Membrane phospholipids and cytokine interaction in schizophrenia","volume":"59","author":"Yao","year":"2004","journal-title":"Int Rev Neurobiol"},{"key":"B29","first-page":"117","article-title":"Phospholipids in schizophrenia","volume-title":"Textbook of Schizophrenia","author":"Mahadik","year":"2006"},{"key":"B30","first-page":"298","article-title":"Cognition, dopamine and bioactive lipids in schizophrenia","volume":"3","author":"Condray","year":"2011","journal-title":"Front Biosci (Schol Ed)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1089\/ars.2010.3603","article-title":"Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view","volume":"15","author":"Yao","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"B32","doi-asserted-by":"publisher","first-page":"D112","DOI":"10.1051\/ocl\/2015054","article-title":"Phospholipid, arachidonate and eicosanoid signaling in schizophrenia","volume":"23","author":"Messamore","year":"2016","journal-title":"Oilseeds Fats Crops Lipids"},{"key":"B33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1744-9081-8-61","article-title":"GABAergic neuroactive steroids: a new frontier in bipolar disorders?","volume":"8","author":"Carta","year":"2012","journal-title":"Behav Brain Funct"},{"key":"B34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00213-002-1257-1","article-title":"Neurosteroids in depression: a review","volume":"165","author":"van Broekhoven","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yhbeh.2005.12.002","article-title":"Sex hormones, central nervous system and pain","volume":"50","author":"Aloisi","year":"2006","journal-title":"Horm Behav"},{"key":"B36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/WCO.0b013e32833735cf","article-title":"Neurosteroids and epilepsy","volume":"23","author":"Biagini","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"653570","DOI":"10.1155\/2011\/653570","article-title":"Hypothesis: the role of sterols in autism spectrum disorder","volume":"2011","author":"Lee","year":"2011","journal-title":"Autism Res Treat"},{"key":"B38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1196\/annals.1286.007","article-title":"Neurosteroid biosynthesis in the human brain and its clinical implications","volume":"1007","author":"Stoffel-Wagner","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"B39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0031-6997(24)01395-4","article-title":"Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system","volume":"51","author":"Mensah-Nyagan","year":"1999","journal-title":"Pharmacol Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/sj.bjp.0701046","article-title":"The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations","volume":"120","author":"Barbaccia","year":"1997","journal-title":"Br J Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0893-133X(01)00254-8","article-title":"Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat","volume":"25","author":"Barbaccia","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1006\/abio.1999.4384","article-title":"Profiling neurosteroids in cerebrospinal fluids and plasma by gas chromatography\/electron capture negative chemical ionization mass spectrometry","volume":"277","author":"Kim","year":"2000","journal-title":"Anal Biochem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0165-6147(91)90531-V","article-title":"Non-genomic and genomic effects of steroids on neural activity","volume":"12","author":"McEwen","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fendo.2011.00044","article-title":"Neurosteroids and GABA-A receptor function","volume":"2","author":"Wang","year":"2011","journal-title":"Front Endocrinol"},{"key":"B45","first-page":"1","article-title":"Neurosteroids: of the nervous system, by the nervous system, for the nervous system","volume":"52","author":"Baulieu","year":"1997","journal-title":"Recent Prog Horm Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA (A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1126\/science.2422758","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor","volume":"232","author":"Majewska","year":"1986","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.tips.2016.04.003","article-title":"Clinical potential of neurosteroids for CNS disorders","volume":"7","author":"Reddy","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0039-128X(01)00170-2","article-title":"Withdrawal properties of a neuroactive steroid: implications for GABAA receptor gene regulation in the brain and anxiety behavior","volume":"67","author":"Smith","year":"2002","journal-title":"Steroids"},{"key":"B50","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/35007116","article-title":"Benzodiazepine actions mediated by specific [gamma]-aminobutyric acidA receptor subtypes","volume":"404","author":"Rudolph","year":"2000","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","article-title":"Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the \u03b15 subunit of the GABAA receptor","volume":"22","author":"Collinson","year":"2002","journal-title":"J Neurosci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal \u03b15 GABAA receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B53","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1523\/JNEUROSCI.1067-04.2004","article-title":"Requirement of \u03b15-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice","volume":"24","author":"van Rijnsoever","year":"2004","journal-title":"J Neurosci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1111\/j.1460-9568.2004.03642.x","article-title":"GABAA receptors containing the \u03b15 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear","volume":"20","author":"Yee","year":"2004","journal-title":"Eur J Neurosci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0006-8993(01)02565-3","article-title":"Short-term exposure to a neuroactive steroid increases \u03b14 GABA A receptor subunit levels in association with increased anxiety in the female rat","volume":"910","author":"Gulinello","year":"2001","journal-title":"Brain Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1476-5381.1996.tb15221.x","article-title":"Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination","volume":"117","author":"Thompson","year":"1996","journal-title":"Br J Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABAA receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"B58","first-page":"135","article-title":"Does neurosteroid modulatory efficacy depend on GABAA receptor subunit composition?","volume":"1","author":"Puia","year":"1993","journal-title":"Receptors Channels"},{"key":"B59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0006-8993(98)01316-X","article-title":"Subunit dependent modulation of GABAA receptor function by neuroactive steroids","volume":"819","author":"Maitra","year":"1999","journal-title":"Brain Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0028-3908(02)00172-7","article-title":"The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors","volume":"43","author":"Belelli","year":"2002","journal-title":"Neuropharmacology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1023\/A:1012376215967","article-title":"Distinguishing between GABAA receptors responsible for tonic and phasic conductances","volume":"26","author":"Mody","year":"2001","journal-title":"Neurochem Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuropharm.2014.08.003","article-title":"Altered expression of \u03b4GABAA receptors in health and disease","volume":"88","author":"Whissell","year":"2015","journal-title":"Neuropharmacology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tins.2004.03.005","article-title":"Tonically active GABA A receptors: modulating gain and maintaining the tone","volume":"27","author":"Semyanov","year":"2004","journal-title":"Trends Neurosci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0079-6123(07)63014-3","article-title":"Functional regulation of the dentate gyrus by GABA-mediated inhibition","volume":"163","author":"Coulter","year":"2007","journal-title":"Prog Brain Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1523\/JNEUROSCI.4751-07.2008","article-title":"Which GABAA receptor subunits are necessary for tonic inhibition in the hippocampus?","volume":"28","author":"Glykys","year":"2008","journal-title":"J Neurosci"},{"key":"B67","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1523\/JNEUROSCI.16-21-06648.1996","article-title":"Delta subunit inhibits neurosteroid modulation of GABAA receptors","volume":"16","author":"Zhu","year":"1996","journal-title":"J Neurosci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","article-title":"Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors","volume":"136","author":"Brown","year":"2002","journal-title":"Br J Pharmacol"},{"key":"B69","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1523\/JNEUROSCI.22-05-01541.2002","article-title":"Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit","volume":"22","author":"Wohlfarth","year":"2002","journal-title":"J Neurosci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pneurobio.2003.09.001","article-title":"Neurosteroid modulation of GABA A receptors","volume":"71","author":"Lambert","year":"2003","journal-title":"Prog Neurobiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neuropharm.2008.07.050","article-title":"Conserved site for neurosteroid modulation of GABA A receptors","volume":"56","author":"Hosie","year":"2009","journal-title":"Neuropharmacology"},{"key":"B72","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.20-10-03571.2000","article-title":"Pregnenolone sulfate modulates inhibitory synaptic transmission by enhancing GABA(A) receptor desensitization","volume":"20","author":"Shen","year":"2000","journal-title":"J Neurosci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pharmthera.2007.03.011","article-title":"Neurosteroid binding sites on GABA A receptors","volume":"116","author":"Hosie","year":"2007","journal-title":"Pharmacol Ther"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1021\/jm00168a008","article-title":"Synthesis, metabolism, and pharmacological activity of 3 alpha-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes","volume":"33","author":"Purdy","year":"1990","journal-title":"J Med Chem"},{"key":"B75","first-page":"1053","article-title":"Potential clinical uses of neuroactive steroids","volume":"3","author":"Zorumski","year":"2000","journal-title":"Drugs"},{"key":"B76","first-page":"197","article-title":"Structure activity relationship of GABAA-steroids antagonists","author":"Ragagnin","year":"2007"},{"key":"B77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1021\/jm401577c","article-title":"Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of \u03b3-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone","volume":"57","author":"Qian","year":"2014","journal-title":"J Med Chem"},{"key":"B78","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neulet.2007.01.004","article-title":"Neurosteroid modulation of GABAergic neurotransmission in the central amygdala: a role for NMDA receptors","volume":"415","author":"Wang","year":"2007","journal-title":"Neurosci Lett"},{"key":"B79","doi-asserted-by":"publisher","first-page":"140918","DOI":"10.1016\/j.steroids.2011.09.002","article-title":"Neurosteroid modulation of N-methyl-D-aspartate receptors: molecular mechanism and behavioral effects","volume":"76","author":"Korinek","year":"2011","journal-title":"Steroids"},{"key":"B80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0026-895X(25)12923-4","article-title":"Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor","volume":"40","author":"Wu","year":"1991","journal-title":"Mol Pharmacol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0006-8993(89)90024-3","article-title":"Pregnenolone sulfate antagonizes GABA A receptor-mediated currents via a reduction of channel opening frequency","volume":"489","author":"Mienville","year":"1989","journal-title":"Brain Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neuroscience.2005.08.058","article-title":"Subtype-dependence of Nmethyl-D-aspartate receptor modulation by pregnenolone sulfate","volume":"137","author":"Horak","year":"2006","journal-title":"Neuroscience"},{"key":"B83","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0026-895X(25)08656-0","article-title":"3 Alpha-hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons","volume":"46","author":"Park-Chung","year":"1994","journal-title":"Mol Pharmacol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0006-8993(99)01381-5","article-title":"Sulfated and unsulfated steroids modulate gamma-aminobutyric acid A receptor function through distinct sites","volume":"830","author":"Park-Chung","year":"1999","journal-title":"Brain Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0014-2999(86)90077-4","article-title":"A physiological dose of progesterone affects rat striatum biogenic amine metabolism","volume":"125","author":"Di Paolo","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0278-5846(95)00029-U","article-title":"Progesterone releases dopamine in male and female rat striatum: a behavioral and microdialysis study","volume":"19","author":"Petitclerc","year":"1995","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1046\/j.1471-4159.2002.01218.x","article-title":"Progesterone enhances ethanol-induced modulation of mesocortical dopamine neurons: antagonism by finasteride","volume":"83","author":"Dazzi","year":"2002","journal-title":"J Neurochem"},{"key":"B88","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/sj.mp.4002030","article-title":"Progesterone selectively increases amygdala reactivity in women","volume":"13","author":"Van Wingen","year":"2008","journal-title":"Mol Psychiatry"},{"key":"B89","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/syn.1067","article-title":"Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl\/6 mice","volume":"41","author":"Callier","year":"2001","journal-title":"Synapse"},{"key":"B90","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/026988119601000402","article-title":"Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanolone","volume":"10","author":"Motzo","year":"1996","journal-title":"J Psychopharmacol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1385\/ENDO:17:2:077","article-title":"Effect of centrally injected allopregnanolone on sexual receptivity, luteinizing hormone release, hypothalamic dopamine turnover, and release in female rats","volume":"17","author":"Laconi","year":"2002","journal-title":"Endocrine"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1046\/j.1471-4159.1997.69051920.x","article-title":"Sensitization of G protein-coupled benzodiazepine receptors in the striatum of 6-hydroxydopamine-lesioned rats","volume":"69","author":"Tenn","year":"1997","journal-title":"J Neurochem"},{"key":"B93","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1460-9568.2002.02084.x","article-title":"The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens","volume":"16","author":"Roug\u00e9-Pont","year":"2002","journal-title":"Eur J Neurosci"},{"key":"B94","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0163-7258(02)00175-4","article-title":"Multiple roles of protein kinases in the modulation of \u03b3-aminobutyric acid A receptor function and cell surface expression","volume":"94","author":"Brandon","year":"2002","journal-title":"Pharmacol Ther"},{"key":"B95","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2014.09.021","article-title":"Modulation of neurosteroid potentiation by protein kinases at synaptic-and extrasynaptic-type GABA A receptors","volume":"88","author":"Adams","year":"2015","journal-title":"Neuropharmacology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1152\/jn.00204.2010","article-title":"A dynamic role for GABA receptors on the firing pattern of midbrain dopaminergic neurons","volume":"104","author":"Lobb","year":"2010","journal-title":"J Neurophysiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1126\/science.2832949","article-title":"Steroid binding at sigma receptors suggesting a link between endocrine, nervous and immune systems","volume":"240","author":"Su","year":"1988","journal-title":"Science"},{"key":"B98","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/(SICI)1097-4547(19961215)46:6<734:AID-JNR10>3.0.CO;2-U","article-title":"Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10,047 binding to \u03c31 receptors in the mouse forebrain","volume":"46","author":"Maurice","year":"1996","journal-title":"J Neurosci Res"},{"key":"B99","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1073\/pnas.92.9.3774","article-title":"Neurosteroids, via sigma receptors, modulate the [3H] norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus","volume":"92","author":"Monnet","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B100","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0165-0173(99)00041-7","article-title":"Emerging principles of altered neural circuitry in schizophrenia","volume":"31","author":"Benes","year":"2000","journal-title":"Brain Res Rev"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.euroneuro.2014.07.015","article-title":"Glutamate-mediated excitotoxicity in schizophrenia: a review","volume":"24","author":"Plitman","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00002826-200101000-00008","article-title":"A revised excitotoxic hypothesis of schizophrenia: therapeutic implications","volume":"24","author":"Deutsch","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"B103","first-page":"335","article-title":"Endogenous neuroprotective factors: neurosteroids","volume":"58","author":"Wojtal","year":"2006","journal-title":"Pharmacol Rep"},{"key":"B104","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fendo.2011.00050","article-title":"Neuroprotective actions of neurosteroids","volume":"2","author":"Borowicz","year":"2011","journal-title":"Front Endocrinol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1023\/A:1007668213330","article-title":"Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity","volume":"26","author":"Gursoy","year":"2001","journal-title":"Neurochem Res"},{"key":"B106","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature04436","article-title":"Pregnenolone stabilizes microtubules and promotes zebrafish embryonic cell movement","volume":"439","author":"Hsu","year":"2006","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1073\/pnas.0600113103","article-title":"Microtubule-associated protein 2 (MAP2) is a neurosteroid receptor","volume":"103","author":"Fontaine-Lenoir","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1126\/science.7770777","article-title":"Progesterone synthesis and myelin formation by Schwann cells","volume":"268","author":"Koenig","year":"1995","journal-title":"Science"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1161\/01.STR.31.8.1953","article-title":"Dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord ischemia model","volume":"31","author":"Lapchak","year":"2000","journal-title":"Stroke"},{"key":"B110","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/00001756-199803090-00036","article-title":"Neuroprotection by dehydroepiandrosteronesulfate: role of an NF kappa-like factor","volume":"9","author":"Mao","year":"1998","journal-title":"Neuroreport"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1385\/JMN:28:1:3","article-title":"Progesterone treatment of spinal cord injury","volume":"28","author":"De Nicola","year":"2006","journal-title":"J Mol Neurosci"},{"key":"B112","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1006\/exnr.1994.1147","article-title":"Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats","volume":"129","author":"Roof","year":"1994","journal-title":"Exp Neurol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000258709","article-title":"Progesterone and the spinal cord: good friends in bad times","volume":"17","author":"Labombarda","year":"2010","journal-title":"Neuroimmunomodulation"},{"key":"B114","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2826.2004.01121.x","article-title":"Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo","volume":"16","author":"Ciriza","year":"2004","journal-title":"J Neuroendocrinol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsbmb.2012.12.013","article-title":"Allopregnanolone-mediated protective effects of progesterone on tributyltin-induced neuronal injury in rat hippocampal slices","volume":"135","author":"Ishihara","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11745-007-3117-6","article-title":"Estradiol favors the formation of eicosapentaenoic acid (20:5n-3) and n-3 docosapentaenoic acid (22:5n-3) from alpha-linolenic acid (18:3n-3) in SH-SY5Y neuroblastoma cells","volume":"43","author":"Alessandri","year":"2008","journal-title":"Lipids"},{"key":"B117","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1359786810385491","article-title":"A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality","volume":"24","author":"Bradley","year":"2010","journal-title":"J Psychopharmacol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0024-3205(02)01646-6","article-title":"Physical consequences of schizophrenia and its treatment: the metabolic syndrome","volume":"71","author":"Ryan","year":"2002","journal-title":"Life Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/oxfordjournals.schbul.a007139","article-title":"Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms","volume":"30","author":"Thompson","year":"2004","journal-title":"Schizophr Bull"},{"key":"B120","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1073\/pnas.88.10.4553","article-title":"Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain","volume":"88","author":"Purdy","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B121","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0014-2999(94)90123-6","article-title":"Neurosteroids in the brain of handling-habituated and naive rats: effect of CO2 inhalation","volume":"261","author":"Barbaccia","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000126953","article-title":"Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress","volume":"63","author":"Barbaccia","year":"1996","journal-title":"Neuroendocrinology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0091-3057(95)02133-7","article-title":"Stress-induced increase in brain neuroactive steroids: antagonism by abecarnil","volume":"54","author":"Barbaccia","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"B124","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/abio.2000.4841","article-title":"Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography\/mass spectrometry","volume":"287","author":"Vall\u00e9e","year":"2000","journal-title":"Anal Biochem"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.steroids.2004.08.001","article-title":"Studies on neurosteroids XVII. Analysis of stress induced changes in neurosteroid levels in rat brains using liquid chromatography-electron capture atmospheric pressure chemical ionization-mass spectrometry","volume":"70","author":"Higashi","year":"2005","journal-title":"Steroids"},{"key":"B126","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/12207","article-title":"Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues","volume":"2","author":"Crestani","year":"1999","journal-title":"Nat Neurosci"},{"key":"B127","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0301-0082(92)90025-A","article-title":"Neurosteroids: endogenous bimodal modulators of the GABAA receptor Mechanism of action and physiological significance","volume":"38","author":"Majewska","year":"1992","journal-title":"Prog Neurobiol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1046\/j.1471-4159.2000.0750732.x","article-title":"Social isolation-induced decrease in both the abundance of neuroactive steroids and GABAA receptor function in rat brain","volume":"75","author":"Serra","year":"2000","journal-title":"J Neurochem"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1073\/pnas.051628598","article-title":"Brain 5 alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation","volume":"98","author":"Dong","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B130","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/10253890500159022","article-title":"Social isolation stress-induced aggression in mice: a model to study the pharmacology of neurosteroidogenesis","volume":"8","author":"Matsumoto","year":"2005","journal-title":"Stress"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e1130","DOI":"10.1038\/tp.2017.94","article-title":"Therapeutic efficacy of atypical antipsychotic drugs by targeting multiple stress-related metabolic pathways","volume":"7","author":"Cai","year":"2017","journal-title":"Transl Psychiatry"},{"key":"B132","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000126839","article-title":"Regulatory changes in neuroendocrine stress integrative circuitry produced by a variable stress paradigm","volume":"61","author":"Herman","year":"1995","journal-title":"Neuroendocrinology"},{"key":"B133","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1007\/s00213-014-3572-8","article-title":"Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?","volume":"231","author":"Crowley","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"B134","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1523\/JNEUROSCI.4520-04.2005","article-title":"The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression","volume":"25","author":"Wang","year":"2005","journal-title":"J Neurosci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/npp.2009.26","article-title":"Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia","volume":"34","author":"Marx","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.psyneuen.2012.12.025","article-title":"A systematic review of the activity of the hypothalamic-pituitary-adrenal axis in first episode psychosis","volume":"38","author":"Borges","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"B137","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.4088\/JCP.13078tx2c","article-title":"Schizophrenia: overview and dopamine dysfunction","volume":"75","author":"Abi-Dargham","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"B138","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fpsyt.2017.00118","article-title":"GABAergic mechanisms in schizophrenia: linking postmortem and in vivo studies","volume":"8","author":"de Jonge","year":"2017","journal-title":"Front Psychiatry"},{"key":"B139","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","article-title":"GABAA receptor subtypes: therapeutic potential in down syndrome, affective disorders, schizophrenia, and autism","volume":"54","author":"Rudolph","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e21973","DOI":"10.1002\/syn.21973","article-title":"GABAA and GABAB receptor dysregulation in superior frontal cortex of subjects with schizophrenia and bipolar disorder","volume":"71","author":"Fatemi","year":"2017","journal-title":"Synapse"},{"key":"B141","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.euroneuro.2006.10.001","article-title":"Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects","volume":"5","author":"Ritsner","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/0024-3205(92)90563-5","article-title":"The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients","volume":"51","author":"Breier","year":"1992","journal-title":"Life Sci"},{"key":"B143","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0920-9964(01)00367-X","article-title":"Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia","volume":"58","author":"Shirayama","year":"2002","journal-title":"Schizophr Res"},{"key":"B144","first-page":"3","article-title":"Evaluation of serum steroid hormones in schizophrenic patients","volume":"58","author":"Taherianfard","year":"2004","journal-title":"Indian J Med Sci"},{"key":"B145","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archpsyc.1972.01750300025004","article-title":"Plasma androgens in male schizophrenics","volume":"27","author":"Tourney","year":"1972","journal-title":"Arch Gen Psychiatry"},{"key":"B146","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/BF01938331","article-title":"Interaction between dehydroepiandrosterone, cyclic adenosine-3\u2019, 5\u2019-monophosphate and glucose-6-phosphate-dehydrogenase in normal and diseased subjects","volume":"30","author":"Oertel","year":"1974","journal-title":"Experientia"},{"key":"B147","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF02690893","article-title":"Severe psychosis and the adrenal androgens","volume":"27","author":"Howard","year":"1992","journal-title":"Integr Physiol Behav Sci"},{"key":"B148","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jpsychires.2004.08.005","article-title":"Plasma dehydroepiandrosterone levels are strongly increased in schizophrenia","volume":"39","author":"di Michele","year":"2005","journal-title":"J Psychiatr Res"},{"key":"B149","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.schres.2004.03.005","article-title":"Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology","volume":"71","author":"Strous","year":"2004","journal-title":"Schizophr Res"},{"key":"B150","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2147\/NDT.S61406","article-title":"Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia","volume":"10","author":"Beyazy\u00fcz","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B151","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jsbmb.2012.08.009","article-title":"Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia","volume":"133","author":"Bicikova","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0306-9877(97)90258-9","article-title":"Relationship of dehydroepiandrosterone and cortisol in disease","volume":"49","author":"Hechter","year":"1997","journal-title":"Med Hypotheses"},{"key":"B153","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.euroneuro.2003.09.003","article-title":"Elevation of the cortisol\/dehydroepiandrosterone ratio in schizophrenia patients","volume":"14","author":"Ritsner","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.schres.2006.11.020","article-title":"Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder","volume":"90","author":"Gallagher","year":"2007","journal-title":"Schizophr Res"},{"key":"B155","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/15622970109027500","article-title":"Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients","volume":"2","author":"Harris","year":"2001","journal-title":"World J Biol Psychiatry"},{"key":"B156","first-page":"295","article-title":"The 5-HT hypothesis of schizophrenia","volume":"4","author":"Akhondzadeh","year":"2001","journal-title":"IDrugs"},{"key":"B157","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.2174\/138161206778522029","article-title":"5-HT3 receptors","volume":"12","author":"Thompson","year":"2006","journal-title":"Curr Pharm Des"},{"key":"B158","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1517\/14728222.2011.560837","article-title":"Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders","volume":"15","author":"Hayashi","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"B159","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainresbull.2010.04.006","article-title":"N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?","volume":"83","author":"Kantrowitz","year":"2010","journal-title":"Brain Res Bull"},{"key":"B160","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0920-9964(97)00010-8","article-title":"The functional significance of symptomatology and cognitive function in schizophrenia","volume":"25","author":"Velligan","year":"1997","journal-title":"Schizophr Res"},{"key":"B161","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1176\/ajp.156.9.1342","article-title":"Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia","volume":"156","author":"Gold","year":"1999","journal-title":"Am J Psychiatry"},{"key":"B162","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0959-4388(00)00068-4","article-title":"Schizophrenia and cognitive function","volume":"10","author":"Kuperberg","year":"2000","journal-title":"Curr Opin Neurobiol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0197-4580(00)00103-2","article-title":"Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats","volume":"21","author":"Gibbs","year":"2000","journal-title":"Neurobiol Aging"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.neurobiolaging.2011.06.008","article-title":"Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice","volume":"33","author":"Singh","year":"2012","journal-title":"Neurobiol Aging"},{"key":"B165","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1210\/jc.2002-020878","article-title":"Neurosteroid quantification in human brain regions: comparison between Alzheimer\u2019s and nondemented patients","volume":"87","author":"Weill-Engerer","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1073\/pnas.89.5.1567","article-title":"Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it","volume":"89","author":"Flood","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B167","doi-asserted-by":"publisher","first-page":"14033","DOI":"10.1073\/pnas.241503698","article-title":"The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms?","volume":"98","author":"Akwa","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B168","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"B169","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/sj.mp.4001093","article-title":"NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2) receptors-implications for models of schizophrenia","volume":"7","author":"Kapur","year":"2002","journal-title":"Mol Psychiatry"},{"key":"B170","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"B171","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"B172","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF02245063","article-title":"The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task","volume":"116","author":"Mathis","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"B173","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-3565(25)22385-0","article-title":"Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: putative role for allopregnanolone","volume":"270","author":"Romeo","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1097\/00001756-199508000-00025","article-title":"Pregnenolone sulfate antagonizes dizocilpine amnesia: role for allopregnanolone","volume":"6","author":"Cheney","year":"1995","journal-title":"Neuroreport"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0028-3908(96)00041-X","article-title":"The neurosteroid pregnenolone sulfate blocks deficits induced by a competitive NMDA antagonist in active avoidance and lever-press learning tasks in mice","volume":"35","author":"Mathis","year":"1996","journal-title":"Neuropharmacology"},{"key":"B176","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"B177","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","article-title":"Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics","volume":"17","author":"Malhotra","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"B178","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophr Bull"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.npp.1300015","article-title":"Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents","volume":"28","author":"Marx","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0006-3223(99)00305-4","article-title":"Olanzapine increases allopregnanolone in the rat cerebral cortex","volume":"47","author":"Marx","year":"2000","journal-title":"Biol Psychiatry"},{"key":"B181","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00213-002-1006-5","article-title":"The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents","volume":"161","author":"Khisti","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"B182","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0893-133X(01)00261-5","article-title":"Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects","volume":"25","author":"Wadenberg","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"B183","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1001\/archpsyc.60.2.133","article-title":"Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia","volume":"60","author":"Strous","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"B184","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.schres.2005.07.029","article-title":"Improvement of extrapyramidal symptoms following dehydroepiandrosterone (DHEA) administration in antipsychotic treated schizophrenia patients: a randomized, double-blind placebo controlled trial","volume":"79","author":"Nachshoni","year":"2005","journal-title":"Schizophr Res"},{"key":"B185","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.psyneuen.2006.11.002","article-title":"Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial","volume":"32","author":"Strous","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"B186","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/01.jcp.0000237942.50270.35","article-title":"Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial","volume":"26","author":"Ritsner","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/JCP.0b013e31817d86de","article-title":"Hormonal response to dehydroepiandrosterone administration in schizophrenia: findings from a randomized, double-blind, placebo-controlled, crossover study","volume":"28","author":"Strous","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpsychires.2009.07.002","article-title":"Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA","volume":"44","author":"Ritsner","year":"2010","journal-title":"J Psychiatr Res"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.4088\/JCP.09m05031yel","article-title":"Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial","volume":"71","author":"Ritsner","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"B190","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3371\/CSRP.KRBA.013114","article-title":"Adjunctive pregnenolone ameliorates the cognitive deficits in recent-onset schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial","volume":"10","author":"Kreinin","year":"2017","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"B191","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/pcn.12150","article-title":"Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: an 8-week, double-blind, randomized add-on two-center trial","volume":"68","author":"Ritsner","year":"2014","journal-title":"Psychiatry Clin Neurosci"},{"key":"B192","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1007\/s00213-014-3673-4","article-title":"Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia","volume":"231","author":"Marx","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"B193","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jamapsychiatry.2013.245","article-title":"Neurosteroids as therapeutic leads in psychiatry","volume":"70","author":"Zorumski","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"B194","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neubiorev.2012.10.005","article-title":"Neurosteroids, stress and depression: potential therapeutic opportunities","volume":"37","author":"Zorumski","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"B195","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.schres.2015.04.044","article-title":"Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress","volume":"168","author":"Frau","year":"2015","journal-title":"Schizophr Res"},{"key":"B196","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2174\/138161211795049589","article-title":"Steroid 5\u03b1-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders","volume":"17","author":"Paba","year":"2011","journal-title":"Curr Pharm Des"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2018.00073\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:13:00Z","timestamp":1751469180000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2018.00073\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,8]]},"references-count":196,"alternative-id":["10.3389\/fpsyt.2018.00073"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2018.00073","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,8]]},"article-number":"73"}}